Unnamed stage
$6m
Paragen Bio launches in northern Queensland with $6 million investment
A James Cook University hookworm-research biotech, Paragen Bio, has launched with $6 million from Brandon Capital's MRCF, AbbVie Ventures and OneVentures to develop hookworm-derived medicines against autoimmune disease.
Also Brandon Capital portfolio·OneVentures portfolio·SmartCompany·Techboard